Evaluation of Effectiveness and Outcome of Interleukin-6 Inhibitor Treatment in Patients with Systemic Juvenile Idiopathic Arthritis

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Shiari Reza; Roshanzamir Navid; Erfanian Salim Mahsa

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: IMMUNOLOGY AND GENETICS JOURNAL Year:2024 | Volume:7 | Issue:2 Page(s): 66-71

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Evaluation of Effectiveness and Outcome of Interleukin-6 Inhibitor Treatment in Patients with Systemic Juvenile Idiopathic Arthritis

Author(s)

Shiari Reza | Roshanzamir Navid | Erfanian Salim Mahsa | Issue Writer Certificate

Keywords

Interleukine-6 (IL-6); Systemic Juvenile Idiopathic Arthritis (sJIA); Treatment; Tocilizumab

Abstract

Background: Systemic juvenile idiopathic arthritis (sJIA) is determined by prominent multisystemic involvements with onset before the age of 16 years of which IL-6 has a significant role in inflammatory process. Tocilizumab (TCZ) is a human anti-IL-6 receptor monoclonal antibody, which modulates IL-6 activity by blocking its binding to the soluble and membrane-bound IL-6 receptor. No comprehensive study has been done regarding the use of IL-6 inhibitor in the treatment of SJIA patients in Iran. This study was conducted with the aim of investigating the effectiveness and outcome of IL-6 inhibitor treatment in Iranian children with sJIA.
Methods and Materials: This is a case-control study including twenty patients diagnosed with sJIA divided equally in two groups of case and control who received TCZ and corticosteroids respectively. Subsequently, various clinical and laboratory features were compared amongst these two groups.
Results: A significant difference before and after TCZ has been seen in terms of height increase, weight gain, and decrease in leukocytosis, thrombocytosis and ESR, CRP negativity and arthritis improvement.
Conclusions: Considering the favorable effects of TCZ in the control of sJIA, by producing this drug in the country and making it available to patients at a lower cost, it is possible to better control the disease and reduce the harmful effects caused by the disease and reduce the long-term use of corticosteroids.

Multimedia

No record.

Cites

No record.

References

Cite

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.